Figure Technology Solutions Aims for $4 Billion Valuation with Upcoming Nasdaq IPO
September 8, 2025 - 07:40
Figure Technology Solutions, a fintech company leveraging blockchain technology for mortgage and lending services, is preparing for a significant initial public offering (IPO) on the Nasdaq. Co-founded by industry expert Mike Cagney, the San Francisco-based firm is targeting a valuation in the range of $4.1 to $4.3 billion. To achieve this, Figure plans to raise approximately $526 million by offering 26.3 million shares, with an anticipated price set between $18 and $20 each.
The IPO is scheduled to price on September 10, 2025, and represents a pivotal moment for the company as it seeks to expand its market presence and enhance its product offerings. The move to go public underscores the growing interest in blockchain applications within the financial sector, particularly in areas such as real estate lending. Investors and analysts alike will be closely monitoring this IPO, as it could signify a broader trend of fintech companies embracing public markets to fuel their growth strategies.
MORE NEWS
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...